Seeing Is Believing
Currently out of the existing stock ratings of Charles Pitman, 1 are a HOLD (50%), 1 are a BUY (50%).
Analyst Charles Pitman, currently employed at BARCLAYS, carries an average stock price target met ratio of 100% that have a potential upside of 19.82% achieved within 285 days.
Charles Pitman’s has documented 3 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARGX, argenx NV ADR at 06-Aug-2024.
Analyst best performing recommendations are on ARGX (ARGENX NV ADR).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 9/23/2021. The price target of $381.03 was fulfilled within 285 days with a profit of $63.02 (19.82%) receiving and performance score of 0.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$715
$100.24 (16.31%)
$715
11 days ago
(16-Apr-2025)
15/17 (88.24%)
$127.41 (21.68%)
127
Buy
$720
$105.24 (17.12%)
$720
16 days ago
(11-Apr-2025)
27/30 (90%)
$139.06 (23.94%)
160
Buy
$1100
$485.24 (78.93%)
$665
1 months 17 days ago
(10-Mar-2025)
12/13 (92.31%)
$529 (92.64%)
155
Hold
$680
$65.24 (10.61%)
$650
1 months 23 days ago
(04-Mar-2025)
10/11 (90.91%)
$58.75 (9.46%)
160
Buy
$704
$89.24 (14.52%)
$675
1 months 30 days ago
(28-Feb-2025)
2/4 (50%)
$79.3 (12.69%)
56
What Year was the first public recommendation made by Charles Pitman?